Boards should not wait for a digital equivalent of the Cuban Missile Crisis before serious governance gets built.
Merck cut a drug discovery cycle by 33% and ships compliant marketing 80% faster. Mastercard is rethinking fraud disputes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results